Evidence map›Paper›PMID 28458559›Full record

ArticleOncoTargets and therapy2017

Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection.

Jianjun Liu, Shangxiang Chen, Qirong Geng, Xuechao Liu, Pengfei Kong, Youqing Zhan, Dazhi Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Measuring proteins in HChemical science · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jianjun LiuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Shangxiang ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Qirong GengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Xuechao LiuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Pengfei KongState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Youqing ZhanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.
Dazhi XuState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral studies have highlighted the prognostic value of the albumin-globulin ratio (AGR) in various kinds of cancers. Our study was designed to assess whether AGR is associated with the prognosis of gastric cancer patients. PATIENTS AND

methodsA total of 507 gastric cancer patients between 2005 and 2012 were included. The AGR was defined as the ratio of serum albumin to nonalbumin and calculated by the equation: albumin/(total protein - albumin). Furthermore, AGR was divided into two groups (low and high) using the X-tile software. Survival analysis stratified by AGR groups was performed.

resultsThe mean survival time for each group was 36.62 months (95% CI: 33.92-39.32) for the low AGR group and 48.95 months (95% CI: 41.93-55.96,

conclusionPretreatment AGR is a significant and independent predictive factor of prognosis.

Indexed as

albumin–globulin ratiogastric cancerinflammationsurvival

Identifiers

PMID28458559
PMCPMC5402880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.